Skip to main content

Niall Pearson

Director and Head of Corporate Broking & Sales at Hybridan LLP, a London small-cap broker, and regular UK Investor Magazine podcast guest.

Feb 19, 2025

6:55
What's that going to be used for and what's that going to help Physiomix achieve?
6:59
So these Innovate grants are great.
7:02
I mean, firstly, they're hugely competitive.
7:05
Ever since we came out of the EU, there's been a real lack of funding from Europe in life sciences, unfortunately.
7:13
So they're few and far between.
7:15
So I think it's great industry support.
7:17
recognition and validation for the work we're doing.
10:23
Yeah, I think let's start, Neil, if you could give us an introduction to MediaZest and what they do, please.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.